Advertisement
Canada markets open in 8 hours 49 minutes
  • S&P/TSX

    22,690.39
    -36.41 (-0.16%)
     
  • S&P 500

    5,505.00
    -39.59 (-0.71%)
     
  • DOW

    40,287.53
    -377.47 (-0.93%)
     
  • CAD/USD

    0.7284
    +0.0002 (+0.02%)
     
  • CRUDE OIL

    80.53
    +0.40 (+0.50%)
     
  • Bitcoin CAD

    93,177.27
    +1,053.66 (+1.14%)
     
  • CMC Crypto 200

    1,399.47
    +68.57 (+5.15%)
     
  • GOLD FUTURES

    2,405.80
    +6.70 (+0.28%)
     
  • RUSSELL 2000

    2,184.35
    -13.94 (-0.63%)
     
  • 10-Yr Bond

    4.2390
    +0.0500 (+1.19%)
     
  • NASDAQ futures

    19,778.25
    +65.25 (+0.33%)
     
  • VOLATILITY

    16.52
    +0.59 (+3.70%)
     
  • FTSE

    8,155.72
    -49.17 (-0.60%)
     
  • NIKKEI 225

    39,529.29
    -534.50 (-1.33%)
     
  • CAD/EUR

    0.6685
    -0.0005 (-0.07%)
     

Khiron Life Sciences Corp. to Present at Investor Summit Group's Q3 Virtual Conference

Toronto, Ontario--(Newsfile Corp. - August 10, 2022) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (FSE: A2JMZC) ("Khiron" or the "Company"), a global leader in medical cannabis throughout Europe and Latin America, today announced that Alvaro Torres, CEO and Director of the Company will be attending the Q3 Virtual Investor Summit.

Event:

Q3 Investor Summit

Date:

August 16 & 17th, 2022

Presentation:

August 17 @ 9:30am ET

Location:

https://us06web.zoom.us/webinar/register/WN_S-00o_wYSdW6qMjhxVfDeg

 

ADVERTISEMENT


About Khiron Life Sciences:

Khiron is a leading vertically integrated international medical cannabis corporation with core operations in Latin America and Europe. Leveraging medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific, product innovation, and cannabis operations expertise to drive prescriptions and brand loyalty with patients worldwide. The Company has a sales presence in Colombia, Peru, Germany, United Kingdom, and Brazil and is positioned to commence sales in Mexico. The Company is led by co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and Board of Directors.

Visit Khiron online at https://investors.khiron.ca.

Linkedin https://www.linkedin.com/company/khiron-life-sciences-corp/

Investor Contact:
Paola Ricardo
Investors@khiron.ca
+1 (647) 556-5750

Media Contacts:
Khrion Europe
Peter Leis
Pleis@khiron.ca

Khiron Latin America
Carolina Gomez
Mgomez@khiron.ca

About Investor Summit Group
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q3 Investor Summit will take place virtually, featuring 90+ companies and over 500 investors comprising institutional investors, family offices, and high net worth investors. Sectors Participating: Biotech, Communication Services, Consumer, Energy, Energy/Tech, Financial, Healthcare, Industrials, Materials, Real Estate, Technology, and Tech/Crypt. Contact: info@investorsummitgroup.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/132874